Susquehanna International Group, LLP Adicet Bio, Inc. Call Options Transaction History

Susquehanna International Group, LLP

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Aug 11, 2023	SELL	$2.13 - $7.13 $4,899 - $16,399	-2,300 Reduced 17.97%	10,500 $25,000
Q1 2023 May 16, 2023	SELL	$5.52 - $9.23 $34,776 - $58,149	-6,300 Reduced 32.98%	12,800 $73,000
Q4 2022 Feb 14, 2023	SELL	$7.72 - $21.27 $136,644 - $376,479	-17,700 Reduced 48.1%	19,100 $170,000
Q3 2022 Nov 14, 2022	SELL	$13.43 - $18.74 $135,643 - $189,273	-10,100 Reduced 21.54%	36,800 $523,000
Q2 2022 Aug 15, 2022	BUY	$10.26 - $20.81 $216,486 - $439,091	21,100 Added 81.78%	46,900 $685,000
Q1 2022 May 16, 2022	BUY	$11.53 - $19.97 $297,474 - $515,225	25,800 New	25,800 $515,000

59.2M

4.2K

6.7K

Ticker ACET
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,030,800
Market Cap $38.4M
Description
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.